Psoriasis and staphylococcus aureus skin colonization in Moroccan patients by Elfatoiki, Fatima Zahra et al.




Psoriasis and staphylococcus aureus skin colonization in Moroccan patients 
 
Fatima Zahra Elfatoiki1,2,&, Mohamed El Azhari3, Assiya El Kettani4, Zineb Serhier4, Mohamed Bennani Othmani4, Mohamed 
Timinouni3, Hakima Benchikhi1, Soumiya Chiheb1, Hassan Fellah2 
 
1Department of Dermatology, Ibn Rochd UHC of Casablanca, Morocco, 2Laboratory of Immunology, faculty of medicine, Casablanca, Morocco, 
3Laboratory of Microbiology, Pasteur Institute, Casablanca, Morocco, 4Laboratory of Medical informatics, faculty of medicine, Casablanca, Morocco 
 
&Corresponding author: Fatima Zahra Elfatoiki, Department of Dermatology, Ibn Rochd UHC of Casablanca, Morocco        
 
Key words: Antimicrobial peptides, innate immunity, nasal carriage, psoriasis, skin colonization, staphylococcus aureus 
 
Received: 02/06/2015 - Accepted: 28/07/2015 - Published: 08/02/2016 
 
Abstract  
Psoriatic lesions are rarely complicated by recurrent infections. The aim of our study is to determine skin colonisation and nasal carriage of 
Staphylococcus aureus in patients with psoriasis and in healthy persons. Patients and methods: a comparative study that include 33 patients with 
psoriasis and 33 healthy persons.Samples were taken from lesional and non lesional psoriatic skin and from healthy skin of control group. For S. 
aureus nasal carriage, we used sterile cotton tipped swabs. Out of165 samples (66 skin samples and 33 nasal swabs), 26 S. Aureus strains were 
isolated in 26 persons, 57.69% in the control group and 42.3% in the psoriasisgroup. S. aureus skin colonization was found in one case (3%) 
inlesional psoriatic skin vs 9 cases (27.3%) in control skin OR=0.08 IC 95% (0.01-0.70) p=0.02 and in 12,1% in non lesional soriatic skin vs 27, 
3% in control skin (p =0,13). This colonization was less important in lesional psoriatic skin (3%) than in non lesional psoriatic skin (12.1%) p= 
0.20. Nasal screening identified (7/33) 21, 21% S. aureus carriers in psoriasis group and in control group. Our results are in consensus 
withliterature findings. They have confirmed the importance of antimicrobial peptides in Innateimmunity of human skin. These peptides are 
normally produced bykeratinocytes in response to inflammatory stimuli such as psoriasis. Their high expression in psoriasis skin reduces the risk of 
skin infection and skin colonization with S. Aureus. 
 
 
Pan African Medical Journal. 2016; 23:32 doi:10.11604/pamj.2016.23.33.7198 
This article is available online at: http://www.panafrican-med-journal.com/content/article/23/33/full/ 
 
© Fatima Zahra Elfatoiki et al. The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original 









Pan African Medical Journal – ISSN: 1937- 8688   (www.panafrican-med-journal.com) 
Published in partnership with the African Field Epidemiology Network (AFENET). (www.afenet.net) 
 










Psoriasis is a chronic inflammatory skin disease which is thought to 
affect up to 5% of the world's population [1]. In the Maghreb, the 
prevalence of psoriasis was estimated at 12.08/1000 and in 
Morocco, it was estimated at 15.04/1000 [2]. This prevalence is 
probably underestimated due to the misunderstanding of the 
disease in our context [2]. For a long time, psoriasis has been 
thought to be an epidermal disease because of the increase in the 
keratinocytes proliferation rate and the shortening of the duration of 
their cell cycle [3]. However, current concepts of pathogenesis 
indicate the contribution of genetic, immunologic and environmental 
factors [4]. The presence of bacteria on and in the skin was also 
considered in the pathogenesis of psoriasis. There is also evidence 
that chronic plaques of psoriasis are related to streptococci in the 
throat [5]. Other microorganisms such as S. Aureus which usually 
resides on the skin, has also been implicated in the pathogenesis of 
psoriasis [6]. The plaques of psoriasis are rarely complicated by 
recurrent infections with bacterial, viral, and fungal pathogens. 
About 7 percent of patients with psoriasis have bacterial or viral skin 
infections, as compared with 30 percent of patients with atopic 
dermatitis [7]. Few studies were conducted to identify the colonising 
bacteria in psoriatic lesions [8].The aim of our study is to compare 
skin colonisation and nasal carriage of S.aureus in patients with 





Patients: this is a comparative study performed in a university 
outpatient setting for 6 months. The study participants included 33 
patients with psoriasis vulgaris and 33 healthy subjects. The 
inclusion criteria were patients with chronic plaque psoriasis aged 
over 16 years. None of the patients had received ultraviolet light or 
systemic therapies previously and none had received topical 
corticosteroids or antibacterial treatment for at least two weeks 
before enrollment. The study got approval from the Research and 
Ethical Committee of the Faculty of Medicine and Pharmacy of 
Casablanca, Hassan II University. The patients and healthy persons 
signed a written consent after being informed about the study.  
  
Collection of S. aureus: S. aureus skin colonization was obtained 
using Count- Tact Agar plates (Bio-Mérieux, Marcy l'Etoile, France). 
Specimens were collected in the psoriasis group from the psoriasis 
plaques and from non lesional skin of the back and in the control 
group from healthy skin of the back. For S. aureus nasal carriage, 
we used sterile cotton tipped swabs. The specimens were obtained 
by 5 rotations in each anterior nare of patients and healthy persons. 
All samples were quickly sent to the bacteriological laboratory.  
  
Isolation and identification of S. aureus: the 
studywasconductedat the Laboratory of Molecular Bacteriology of 
the Pasteur institute, Casablanca, Morocco. The Count- Tact Agar 
plates were incubatedaerobicallyat 36°C for 24 to 48 h. The nasal 
swabs were inoculated on Chapman agar (local production 
according to its composition), and incubated at the same conditions. 
After incubation, The colonies were identified on the basis of their 
morphologies, mannitol fermentation, catalase test and Gram 
staining, coagulase activity on rabbit plasma (Bio-Mérieux, Marcy 
l´Etoile, France), production of clumping factor (Pastorex Plus-
Staph, Bio-Rad, Marnes-la-Coquette, France) and biochemical 
features using theApi Staph Bio-Mérieux France microorganism 
identification test kit. The homogeneous strains were stored at 4°C 
in nutrient agar until use, and at -20°C in glycerol stocks using 
commercial Cryobilles (AES Laboratoire, France).  
  
Antimicrobial resistance: Antibiotic sensitivity of S. aureus 
strains was obtained using the agar disc diffusion method on M-H 
medium (Bio-Rad, France) according to the recommendations given 
by the CA-SFM (2012). The following antimicrobial agents (Bio-Rad, 
France) were tested: cefoxitin (30 µg), penicillin G (6 µg), 
tetracycline (30 µg), erythromycin (15 µg), lincomycin (15 µg), 
pristinamycin (15 µg), kanamycin (30 µg), tobramycin (30 µg), 
gentamicin (10 µg), chloramphenicol (30 µg), rifampicin (5 µg), 
fosfomycin (50 µg), pefloxacin (5 µg), 
trimethoprim/sulfamethoxazole (1.25/23.75 µg), fusidic acid (10 µg) 
and vancomycin (30 µg). S.aureus isolates were considered as 
multidrug resistant (MDR) when they were resistant to 3 or more of 
the antibiotics listed above.  
  
Methicillin sensitivity: Methicillin susceptibility was studied by 
using agar screen plates on Muller-Hinton (M-H) agar (Bio-Rad, 
France) with 30 µg/ml of cefoxitin disc as recommended by the 
French Microbiological Society Antibiogram Committee (CA-SFM 
2012). Inhibition diameter around cefoxitin disks less than 27 mm 
after incubation at 36°C for 18-24 h. reflects MRSA suspicion. MRSA 
U2A1593 and methicillin-susceptible S. aureus U2A1594 provided by 
Pasteur Institute (Paris, France) were used as controls.  
  
Statistical Analysis: Data was analyzed using SPSS statistical 
software, version 16.0 (IBM, Chicago, USA). Chi-Square test was 
used to assess the differences between proportions of S. aureus 
strains isolated in psoriasis lesional skin, psoriasis non-lesional skin 
and control skin. Odds Ratio was calculated to assess the 
association between S. aureus skin colonization and psoriasis. A (p-





Out of 33 psoriasis patients 10 were women (30. 3%) and their 
mean age at the time of enrollment was 43. 21(SD=15.80). Of the 
33 control individuals, 14 were women (42, 4%) and their mean age 
at the time of enrollment was 38. 94 (SD=14. 35). Diabetes was 
found in 3 patients in the psoriasis group versus 2 persons in the 
control group. In the 165 samples (66 skin samples and 33 nasal 
swabs) obtained from 66 subjects, a total of 26 S. aureus strains 
was isolated in 26 persons, 15/26 (57. 69%) in the control group 
and 11/26 (42. 3%) in the psoriasis group (Table 1).  
  
Cutaneous colonization: S. aureus skin colonization was found in 
one case (3%) in lesional psoriatic skin versus 9 cases (27.3%) in 
control skin OR=0.08 IC95% (0.01-0.70) (p=0.02) and in 4 cases 
(12.1%) in non lesional psoriatic skin versus 9 cases (27. 3%) in 
control skin OR=0.37 IC95% (0.10-1.34) (p =0.13). This colonization 
was less prevalent in lesional psoriatic skin (3%) than in non 
lesional psoriatic skin (12.1%) OR=0.23 IC95% (0.02-2.15) p= 0.20. 
Bacterial load of S. aureus was more important in control skin. 
Intense bacterial load of S. aureus (> 300 colonies) was not found 
in lesional psoriatic skin however it was found in 3% in non lesional 
psoriatic skin and in 9.1% in control skin, but these associations 
were not significant too.  
  
Nasal carriage: Nasal screening identified 21, 21% S. aureus 
carriers in psoriasis group and 21, 21% S. aureus carriers in control 
group.  
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Antibiotic susceptibility: A total of 10 various resistance 
phenotypes were found for the 26 S. aureus strains isolated (Table 
2). The control skin isolates showed the highest number of 
resistance (Table 3). Wild-type phenotype (S. aureus susceptible to 
all antimicrobial agents tested) was found in one nasal carriage in 
the psoriasis group and Methicillin resistant S. aureus (MRSA) was 
found in three cases (12%) in control skin. Multi-resistance to three 
antibiotic classes or more was not observed in lesional psoriatic skin 
isolates while 1 (3%) and 2 (6.1%), Multi-resistant S. aureus were 
found respectively in non lesional psoriatic skin and in control skin. 





In our study, we have revealed that the percentage of S. aureus 
colonization was significantly higher in the control skin than in the 
lesional psoriatic skin (27.3% vs 3%) OR=0.08 IC95% (0.01-0.70) 
(p=0.02). Thus, the psoriasis is a protective factor against skin S. 
aureus colonization. This difference was already reported by Fahlen 
et al [8] in 2012 who studied the distribution of bacterial microbiota 
in normal and psoriatic skin. In that study, this bacterial microbiota 
was more important in normal skin compared with psoriatic skin. 
Moreover, Staphylococcus in both limbs and trunk was more 
abundant in control group skin compared with psoriasis group skin. 
They suggested that this difference was disease-related and that 
the psoriasis could protect against bacterial colonization. In another 
study [9] comparing S. aureus infection and antimicrobial peptides 
in patients with atopic dermatitis, psoriasis and in normal subjects; 
the authors highlighted the role of antimicrobial peptides in innate 
immunity of human skin and in the ability of the skin to resist 
bacterial infection. They explained that Cathelicidins (LL-37) and 
defensins (HBD-2) belonging to this antimicrobial peptides family 
contribute to hostdefense against S. aureus.  
 
The results of this study showed significantly lower expression of 
HBD-2 mRNA and LL-37 mRNA in atopic lesions than in psoriatic 
lesions (P=0.009 and P=0.02, respectively). The combination of LL-
37 and HBD-2 showed synergistic antimicrobial activity by effectively 
killing S. aureus. They concluded that a deficiency in the expression 
of antimicrobial peptides may account for the susceptibility of 
patients with atopic dermatitis to skin infection with S. aureus. The 
antimicrobial peptides HBD-2 and LL-37 are normally produced by 
keratinocytes in response to inflammatory stimuli such as psoriasis 
or injury [10]. Their high expression in psoriasis skin reduces the 
risk of skin infection and skin colonization with S. aureus [9]. During 
the study, we have also found that S. aureus colonization was less 
important in non lesional psoriatic skin (12.1%) than in control skin 
(27.3%) however the difference was not significant (p= 0.13). It 
has recently been reported that the skin flora varies depending on 
the site from which the samples are taken [11, 12]. The authors 
divided the body surface into three groups: sebaceous, moist and 
dry and found that bacterial load varied within these skin sites [11, 
13]. However, in our study, all skin biopsies of non lesional psoriatic 
skin and control skin were taken from the back. Thus, the difference 
between S. aureus skin colonization in non lesional psoriatic skin 
and control skin is not related to the site of skin biopsy, but rather 
to antimicrobial peptides production. These results are in consensus 
with findings by Peck and al [9] who confirmed the absence of HBD-
2 and LL-37 in normal skin compared with psoriatic skin. These 
antimicrobial peptides are up-regulated under inflammatory 
conditions such as psoriasis [10,13].  
 
Thus in our study, HBD-2 and LL-37 could be present in non lesional 
psoriatic skin since psoriasis is an inflammatory disease with a 
production of systemic inflammatory cytokines. These cytokines 
could lead to increased synthesis of antimicrobial peptides by 
keratinocytes even in non lesional psoriatic skin but in low rates. 
This hypothesis could explain the poor colonization with S. aureus in 
non lesional psoriatic skin (12.1%) compared with control skin 
(27.3%) and in lesional psoriatic skin (3%) compared with non 
lesional psoriatic skin(12.1%). Moreover, intense bacterial load was 
more important in control skin followed by non lesional psoriatic skin 
then by lesional psoriatic skin. This difference may be related to a 
local production of antimicrobial peptides which is more important in 
psoriatic skin [9]. S. aureus nasal carriage rate in the present study 
was found to be 21, 21% in both psoriasis group and control group. 
These findings are consistent with figures that usually quoted for S. 
aureus nasal carriage of 20-40% [14]. When assessing the 
susceptibility to antibiotics of the 26 S. aureus strains, the control 
group showed the highest number of resistance. MRSA was found in 
12% of isolates, all originating in control group skin. Multi-resistance 
to three antibiotic classes or more was not observed in lesional 
psoriatic skin isolates compared with 3% and 6.1% multi-resistant 
S. aureus respectively in non lesional psoriatic skin and in control 
skin. The difference was not statistically significant. Further studies 






Our study suggests that skin S. aureus colonization from control and 
psoriasis groups shows some differences. However, the number of 
samples was very limited and further work is needed to investigate 
these possible differences and to compare the expression of 
antimicrobial expression in different sites.  
 
What is known about this topic 
 
• Psoriasis lesions are rarely complicated by recurrent 
infections. 
•  
What this study adds 
 
• S. aureus colonization was more important in normal skin 
of control group compared with psoriatic skin.  
• S. aureus colonization was more important in non lesional 
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Tables 
 
Table 1: Distribution of S. aureus isolated in psoriasis and control 
groups  
Table 2: Resistance phenotype profile of S. aureus strains isolated 
in psoriasis and control groups  
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Table 1: distribution of S. aureus isolated in psoriasis and control groups 
 Psoriasis group=11(42,3%) Control group=15(57,69%) 
 Nas. carriage NLPS LPS Nas. carriage control skin 
S. aureus isolated 7 4 1 7 9 
NLPS : non lesionalpsoriatic skin/ LPS : lesionalpsoriatic skin. In psoriasis group one S. aureus strainwasfound in both 
NLPS and nasal carriage and in control group one S. aureus strainwasfound in both control skinand nasal carriage 








































Frequency in psoriasis group 
n(%) 
Frequency in control  
group 
n(%) 
PG 7 (21,21%) 7(21,21%) 
FA 1(3,03%) 0 
PG,TE 0 2(6,06%) 
PG, FA 1(3,03%) 0 
PG, Pef 0 1(3,03%) 
PG, E 0 2(6,06%) 
PG, Fox 0 1(3,03%) 
PG,FA, C, Sxt, E, RF 1(3,03%) 0 
PG,Fox, Pef, FA, C, L,  RF 0 1(3,03%) 
PG, Fox, FA, C,L, RF 0 1(3,03%) 
Table 3: S. aureus antibiotic suscepibility in psoriatic and control groups 
Antimicrobial psoriasis group  n(%) control group n(%) 
PG 9 (27,27%) 14(42,42%) 
FA 3(9,09%) 2 (6,06%) 
TE 0 2(6,06%) 
E 0 2(6,06%) 
Pef 0 2(6,06%) 
Fox 0 3(9,09%) 
Sxt 1(3,03%) 0 
RF 1(3,03%) 2(6,06%) 
C 1(3,03%) 2(6,06%) 
L 0 2(6,06%) 
